New agents, emerging strategies, and optimization of established regimens are changing the delivery of breast cancer therapy. Over the past decade, tremendous progress in the treatment of breast cancers has led to improved outcomes for patients, but has also complicated clinical management in this setting. We are excited to announce the 2nd Annual Paris Breast Cancer Conference™, a comprehensive educational conference designed to help practitioners place emerging information into the context of landmark clinical trial data and established standards of care, with the goal of ultimately improving the care they provide to their patients with breast cancers.
This practical and interactive multiday program features a faculty of leading international experts who will provide up-to-date information and guidance via didactic lectures, question-and-answer sessions, and extended interactive, case-based panel discussions. This format will enable participants to engage the faculty in a direct exchange of perspectives, personal experiences, and strategies related to clinical challenges in the management of breast cancers.
This meeting is not to be missed! The activity will to continue the legacy and tradition of Physicians’ Education Resource®, LLC, in providing clinicians with the knowledge and confidence to maintain state-of-the-art care and to optimize outcomes for patients with cancer.
This educational activity is directed toward health care professionals who practice primarily outside of the United States. It is specifically designed for medical oncologists and other health care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc) involved in the treatment and management of patients with breast cancer.
At the conclusion of this activity, participants should be better prepared to:
Fabrice André, MD, PhD
Professor in the Department of Medical Oncology,
Institut Gustave Roussy,
Nicholas Turner, MD, PhD
Academic Consultant Medical Oncologist Biomedical Research Centre
The Royal Marsden NHS Foundation Trust
The Institute of Cancer Research
London, United Kingdom
Community Practice Connections™: New Frontiers in Immuno-Oncology for Microsatellite Instability-High Cancers
Aug 29, 2018
Aug 31, 2018